Antihypertensive efficacy of the oral direct renin inhibitor aliskiren as add-on therapy in patients not responding to amlodipine monotherapy.

Journal of clinical hypertension (Greenwich, Conn.)

Volumn 9, Issue 10, 2007, Pages 742-750

  Drummond, Waymon ^a   Munger, Mark A ^a   Rafique Essop, Mohammed ^a   Maboudian, Mojdeh ^a   Khan, Mahmudul ^a   Keefe, Deborah L ^a  

^a Renaissance Research and Hypertension of Texas   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALISKIREN; AMIDE; AMLODIPINE; ANTIHYPERTENSIVE AGENT; FUMARIC ACID DERIVATIVE; RENIN;

AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ANTAGONISM; DRUG COMBINATION; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL;

AGED; AMIDES; AMLODIPINE; ANTIHYPERTENSIVE AGENTS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; FUMARATES; HUMANS; MALE; MIDDLE AGED; RENIN;

EID: 36248931230     PISSN: 15246175     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-6175.2007.06614.x     Document Type: Article

References (0)